Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people

its decision making 3.18 A patient organisation and clinical expert raised several potential equalities issues. They noted that people with Black, Asian and minority ethnic family backgrounds are more likely to have elevated triglycerides. The patient organisation also commented that people living in England's most deprived areas are almost 4 times more likely to die prematurely from cardiovascular disease than those in the least deprived. It also explained that compared with the general population, people with severe mental illness are more likely to develop and die from preventable conditions, including cardiovascular disease. It also noted that people with learning disabilities are at increased risk of developing cardiovascular disease. The clinical expert noted that some religions have restrictions on fish products. The committee considered these to be important issues. The committee concluded that its recommendation for icosapent ethyl would apply to all patients and that the recommendation would not affect people protected by the equality legislation any differently. End of life criteria do not apply 3.19 NICE's advice about life-extending treatments for people with a short life expectancy did not apply. The committee has not seen evidence of additional benefits that are not captured in the cost-effectiveness analysis 3.20 The clinical
